PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Although the effect of the E167K variant is lower compared to PNPLA3 I148M, the individuals carrying both I148M and E167K variants had a double or additive risk of having NAFLD [86], indicating the gene–gene interplay in the disease.